Showing results (121-130 of 139) with videos related to

Sort By:
Pageof 14
British Journal of Haematology|November 12, 2023
Survival outcomes in patients with acute myeloid leukaemia who received subsequent therapy for relapse in QUAZAR AML-001Farhad Ravandi, Hartmut Döhner, Andrew H Wei, et al.
Clinical Transplants|January 1, 1997
Results of kidney transplantation from 1979 to 1997 at Yonsei UniversityK Park, S I Kim, Y S Kim, et al.
Melanoma Research|September 22, 2007
Dendritic cell immunotherapy for stage IV melanomaMichael G E O'Rourke, Maree K Johnson, Catherine M Lanagan, et al.
European Journal of Trauma and Emergency Surgery : Official Publication of the European Trauma Society|October 30, 2015
The relationship between processes and outcomes for injured older adults: a study of a statewide trauma systemN N Saillant, E Earl-Royal, J L Pascual, et al.
Yonsei Medical Journal|May 24, 2001
An analysis of 4,514 cases of renal biopsy in KoreaI J Choi, H J Jeong, D S Han, et al.
Immunology and Cell Biology|May 10, 2006
Immunological characteristics correlating with clinical response to immunotherapy in patients with advanced metastatic melanomaJulia A Marshall, Trevor H Forster, David M Purdie, et al.
Kisaengch'Unghak Chapchi. the Korean Journal of Parasitology|December 1, 1989
[The prevalence of head louse infestation among urban and rural children in Korea]K S Pai, M S Park, Y S Lee, et al.
The Journal of Vascular Access|July 9, 2008
Vena cava filters: a synopsis of complications and related topicsS P Stawicki, C A Sims, R Sharma, et al.
Current Molecular Medicine|March 4, 2015
Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophreniaJ M Coughlin, T Tanaka, A Marsman, et al.
Blood|August 12, 2022
Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidineHartmut Döhner, Andrew H Wei, Gail J Roboz, et al.
Pageof 14